Business & Finance
Essa Pharma sets ex-dividend date and due bill trading for USD80m capital return
15 August 2025 - ESSA Pharma Inc. (NASDAQ:EPIX), a Canada-based pharmaceutical company, announced on Thursday that Nasdaq has set August 25, 2025, as the ex-dividend date for its previously disclosed ...
BioDlink's bevacizumab injection secures Colombia and Pakistan marketing authorisation
14 August 2025 - BioDlink, a China-based pharmaceutical company, announced on Wednesday that its self-developed bevacizumab injection biosimilar has received marketing approval from Colombia's Na...
GSK to receive USD370m and future royalties in CureVac/BioNTech settlement
8 August 2025 - Biopharmaceutical company GSK plc (LON:GSK) (NYSE:GSK) announced on Friday that it will receive a USD370m upfront settlement following the resolution of mRNA patent litigation between ...
Everest Medicines expands I-MAB investment
4 August 2025 - Chinese biopharmaceutical company Everest Medicines (HKEX:1952) announced on Friday that it has made a strategic equity investment in I-Mab (Nasdaq Global:IMAB), a US-based biotech com...
Perrigo Announces Quarterly Dividend
31 July 2025 - Perrigo Company plc (NYSE: PRGO), an Ireland-based global provider of Consumer Self-Care Products, announced on Wednesday that its board of directors has declared a quarterly dividend o...
Ridgetech reports net income of USD10.20m in fiscal year 2025
29 July 2025 - Ridgetech Inc (Nasdaq:RDGT), a wholesale distributor of pharmaceutical and other healthcare products in China, announced on Monday its financial results for the fiscal year ended 31 Mar...